Estimating the risk of thrombotic events in people with congenital hemophilia A using US claims data

Conclusion: This analysis suggests that PwcHA are not protected against thrombosis, and provides context to evaluate thrombotic risk of HA treatments.PMID:34676773 | DOI:10.2217/cer-2021-0120
Source: Journal of Comparative Effectiveness Research - Category: General Medicine Authors: Source Type: research